This channel contains presentations that are a part of the CME offerings of Northeast Georgia Health System, Inc. Enduring CME material expires two years from presentation date.
Speaker: Olivia Peralta, MD IM Resident, PGY-3 No Disclosures Objectives: -Pathophysiology of anaerobic and aerobic metabolism - Prevalence of Lactic Acidosis and Prognostic Indications -Types of Lactic Acidosis -Role of Thiamine in the setting of persistent Lactic Acidosis -Approach to and management of Lactic Acidosis
Speaker: Judy Mikhail, PhD, MBA, RN Editor-in-Chief, Journal of Trauma Nursing Program Manager, Michigan Trauma Quality Improvement Program University of Michigan Disclosures: None Objectives: • Identify the outline of a scholarly article, including how to formulate a compelling introduction, effectively discuss methods, present results, and conclude with a powerful discussion that can stimulate further research. • Employ strategies for clarity, conciseness and precision in one's writing, including identifying and rectifying common pitfalls such as passive voice, excessive jargon or verbosity. • Familiarize oneself with the submission and publication process, including publication ethics and the stages of peer review.
Speaker: Brian Schuler, MD System Director, Clinical Cardiac Electrophysiology WellSpan Health, York, PA Disclosures: Speaker and Consultant: Canon Medical, USA Speaker, Consultant, and Medical Advisory Board: Boston Scientific Objectives: •Demonstrate the utility of the CT-Angio Suite for EP/cath procedures. •Review data strongly suggesting CT-guided LAAO is the gold standard of PDL prevention. •Review data demonstrating CT-Angio Suite is a fee-for-service and value-based care champion.
Dr. Bedri Yusuf, Andrei Boyarshinov, Steve Kelly, Kassandra Lawson, Dr. Hellen Ransom, and Dr. Janeane Walker Steve Kelly, Compliance Kassandra Lawson, Associate Counsel, Legal Department Hellen Ransom, PhD, Clinical Ethicist Bedri Yusuf, MD, Chief Physician Executive Janeane Walker, PhD, RN, Director Faculty Development and Educational Outcomes
Speaker: Ruben Ruiz Vega, MD IM Resident, PGY-3 No Disclosures Objectives: • Understand the concept of ctDNA by defining what it is and learning its relevance in cancer research and diagnostics. • Grasp the clinical applications of ctDNA by discovering how ctDNA is utilized in cancer diagnosis, prognosis, treatment monitoring and early detection, and the potential impact on patient care. • Identify the challenges and limitations of working with ctDNA, including issues related to sensitivity and specificity. • Explore ctDNA's role in personalized medicine and its potential for other medical applications.
Speaker: Aleksandros Mihilli, MD PGY-3 IM Resident No disclosures Objectives: •Understand how GLP-1RA function, and their use in diabetes and weight loss •Compare the available GLP-1RA in terms of efficacy, and when to use which •Look at future advancements in the field and what research is currently ongoing
Speaker: Travis Dobbs, MS, APRN, FNP-C No disclosures
Speaker: Alix Schnibben, PharmD, BCACP, CTTS Director, Clinical Quality and Ambulatory Pharmacy Services Ambulatory Care Pharmacist No disclosures. Objectives: -Discuss the growing Opioid Epidemic and related statistics. -Review Federal and Georgia State laws and NGHS policies regarding prescribing controlled substances. -Review how to calculate Morphine Milliequivalent Per Day (MME/day). -Summarize the new 2022 CDC Guidelines for Prescribing Opioids for Chronic Pain. -Discuss nonpharmacologic, nonopioid and opioid pharmacologic therapy options. -Discuss Office Visit Workflow for treatment of chronic pain with opioids.
Speaker: Glen Henry, MD; Medical Director, Cath Lab, Georgia Heart Institute Sanjay Lall, MD, MBA, FACC; Cardiologist; Georgia Heart Institute Speakers have no disclosures Objectives: • Discuss the burden and impact of hypertension. • Discuss the definition and diagnostic evaluation of hypertension. • Discuss the treatment of hypertension.
Speaker: Budder Siddiqui, MD Infectious Diseases, Northeast Georgia Medical Center No disclosures Objectives: • To identify the causes of emerging global infections • To discuss ways to prevent future pandemics
Brittany Parker, MD NGPG Family Medicine Tembele Yangandawele, MD NGPG Family Medicine No Disclosures Objectives: •Review epidemiology of maternal opioid use disorder •Understand pharmacology and use of buprenorphine/naloxone in opioid treatment •Overview of maternal comprehensive opioid addiction program •In-depth review of medication initiation and maintenance during pregnancy and postpartum period •Understand monitoring parameters during initiation and discontinuation •Review of Neonatal Abstinence Syndrome (NAS) Ramification
Speaker: Kevin Kalinsky, MD, MS Professor of Medicine Director, Glenn Family Breast Center Director, Breast Medical Oncology Louisa and Rand Glenn Family Chair in Breast Cancer Research Objectives: - To learn about currently approved ADCs in HER2- breast cancer - To have further understanding of HER2 low breast cancer - To learn about future ADCs Disclosures: Advisory/Consulting: Genentech/Roche, Immunomedics, Seattle Genetics, Daiichi Sankyo, Puma Biotechnology, Mersana, Menarini Silicon Biosystems, Myovant Sciences, Takeda
Speaker: Supriya Mannepalli, MD Disclosures: None Objectives: - Review Infection prevention and control data for 2013 Fiscal year for hospital acquired infections - Review CDC definitions and best practice prevention bundles for hospital acquired infections - Discuss upcoming changes to CDC definitions for CLABSI and Lab ID C. diff reporting
Speaker: Kyle Armstrong, DO Emergency and Inpatient Psychiatry Disclosures: None Objectives: •Discuss screening, brief intervention/treatment, and referral to treatment model of care •Overview of motivational interviewing and other brief treatment modalities •Review various other treatment and recovery models for the treatment of substance use disorder
Speaker: Jane Ellis, MD, PhD Department of Gynecology and Obstetrics Division of Maternal-Fetal Medicine Emory University School of Medicine Disclosures: None Objectives: •Describe basic terminology important in understanding maternal mortality •Review current status of maternal deaths worldwide, in US and in Georgia •Highlight Georgia's leading causes of pregnancy-related and pregnancy-associated deaths •Review recommendations for reducing maternal deaths from Georgia's Maternal Mortality Review Committee
Speaker: Dr. Konstantin Zubelevitskiy No disclosures Objectives: •Introduce the ICU Liberation initiative •Define PADIS guidelines and ABCDEF bundle •Discuss the importance of pain management in the ICU setting •Compare valid and reliable pain assessment tools •Identify challenges in assessing pain •Introduce effective strategies to prevent and manage pain •Discuss working with opioid-dependent patients •Review the case scenario
Speaker: Dr. Abhishek Singh No Disclosures Objectives: •Outline the DSM 5 criteria for substance use disorders •Identify etiologies and pathophysiology of Alcohol use disorders and Stimulant Use disorder •Describe treatment options for Alcohol Use disorder various substance use disorders •Identify how interprofessional team strategies can improve patient outcomes in SUD •Identify and discuss new challenges in SUD
Title: Cardiology Grand Rounds: Cerebral Protection for TAVR Evidence and Rationale Speaker: Alexandra Lansky, MD Professor of Medicine, Section of Cardiology Yale School of Medicine Disclosures: Grant/Research: Emboline, Emblok, Boston Scientific Consultant: MedAlliance, Abiomed, Boston Scientific Objectives: - To review the incidence of stroke after TAVR - To review the timing and mechanisms of stroke after TAVR - To review the evidence for Cerebral Embolic Protections - To review future innovations in cerebral embolic protection
Title: DEA Pain Management and Pharmacokinetics Speakers: Dr. Leena Dutta and Dr. Alix Schnibben Disclosures: Dr. Dutta - none Dr. Schnibben - speakers bureau: GlaxoSmithKline Pharmaceutical vaccines Objectives: - Review history of opioids - Define pharmacokinetics/pharmacodynamics of opioids - Understand different types of pain and how to assess - Consider when to manage pain with non-pharmacologic - Recite how to use the WHO ladder to start pharmacologic management of pain - Understand the difference between tolerance, dependence, pseudo-addiction and addiction
Speaker: Robert O. Cotes, MD Associate Professor at Emory University School of Medicine, Department of Psychiatry and Behavioral Sciences Director Clinical & Research Program for Psychosis at Grady Health System Title: Psychiatry Grand Rounds: From Red Tape to Recovery: How You Can Unlock Clozapine's Game-Changing Potential Disclosures: Grant/Research Support: Otsuka, Roche, Alkermes, Karuna Consultant: Saladax Biomedical, HLS Therapeutics (unpaid) Speakers bureau: Saldax Biomedical Objectives: - List three scenarios for when to obtain TDM for clozapine as per the ASCP/AGNP guideline - List one clinically relevant example of how someone from a specific ethnic or cultural background may metabolize clozapine differently - Describe one possible change the FDA could make to the Clozapine REMS system to improve access
Title: DEA MATE: Changing the bias in treating substance use Speakers: Dr. Kalpana Prasad and Dr. Andrea Huntley No Financial Disclosures
Title: IM Grand Rounds: What are you eating for lunch? The Effects of Diet on Health Speaker: Nina Le, DO, MPH IM Resident PGY3 No financial disclosures Objectives: - Review cardiovascular disease and types of diets - Evaluate literature in support of Mediterranean diet as well as vegetarian diet - Discuss vegetarian dietary patterns and cardiometabolic risk in patients with cardiovascular disease - Discuss how dietary guidelines should change to reflect the emerging evidence in the field
Title: Opiate Use Disorder: Background and Management Speakers: Alison Ruch, MD, FACEP Bedri Yusuf, MD Speakers have no financial disclosures. Objectives: •OUD Background •Opiate non-fatal OD and fatal OD in Northeast Georgia •Role of fentanyl in rising mortality of OUD •CDC's recommendations to combat OD deaths •MOUD Protocol at NGHS
Title: Cardiology Grand Rounds: Lessons Learned from DOAC's and the New Factor XI Anti-thrombotic Therapies Being Studied Speaker: Manesh R. Patel, MD Chief, Division of Cardiology Co-Director, Duke Heart Center Duke Clinical Research Institute Duke University, Durham, NC Disclosures: Research Grants: PACIFIC-AF: Bayer, Janssen, Heartflow, Idorsia, NHLBI, Novartis Advisory Board/Consulting: Bayer, Janssen, Heartflow, Medscape Objectives: •Understand the Net-Benefit of Warfarin and then NOACs in AFib •Understand the use of NOACs and limitations •Understand the Factor XI therapy and promise in A. Fib
IM Grand Rounds: Delirium in Hospitalized Older Adults Speaker: Akshay Kumar, MD PGY-3 IM Resident No Disclosures Objectives: -Identify what constitutes delirium in an institutionalized older adults. -How to appropriately assess and manage delirium in acute setting as per latest guidelines. -Measures healthcare provider should take to prevent onset of delirium in hospitalized setting.
Neuro Science Grand Rounds: UPDATED AHA GUIDELINES FOR THE MANAGEMENT OF ANEURYSMAL SUBARACHNOID HEMORRHAGE Speaker: Andres Ruiz, MD, Neuro Critical Care No Disclosures Objectives: - Review updated algorithm for management through different phases of care - Summarize new recommendations that differ from 2012 guidelines - Review pathophysiology and updated management strategies for delayed cerebral ischemia
Title: ID Grand Rounds: Hepatic Infections Speaker: Merin Varghese, MD Consultant, Infectious Disease Physician Lead, Antimicrobial Stewardship No financial disclosures Objectives: Review common etiologies of liver abscesses Review common fungal etiologies of liver infections Brief overview of pathogens associated with viral hepatitis
Title: Comprehensive Care of the Cardiomyopathy Patient: From Pillars that Sustain to Buttresses that Assist Presented by: J. Eduardo Rame, MD, MPhil, FAHA, FESC Director of Advanced Heart Failure & Cardiac Transplant Thomas Jefferson University Division of Cardiology, Philadelphia, PA Financial Disclosure: Co-Primary Investigator ReSTAGE HF (Thoratec, now Abbott, Inc) Primary Investigagor ADVANCE and ENDURANCE (HeartWare, now Medtronic Inc) National PI: SoPRANO (Macitentan post LVAD, Jannsen) Objectives: 1. To describe the different adaptations of human heart failure 2. To describe the potential for myocardial recovery 3. To describe the pillars of heart failure therapy
Speaker: John Torous, MD, MBI Objectives: - Assess which digital phenotyping data streams could be most useful in helping understand your patients' clinical trajectories and list three risks and benefits of this method of data collection - Apply a digital literacy frame to be able to evaluate which of your patients may most benefit from digital health and which first require training / support - Define digital phenotyping and list three risks and benefits of this method of data collection - List the four stages of the APA app evaluation framework in order of use - Be able to guide a patient through informed decision making in using a mental health related smartphone app
Enduring CME will expire on 6/23/2025 Objectives: 1. Describe the barriers to mental healthcare among Hispanic/Latino communities and their prevalence 2. Utilize screening tools/assessments and strategies to overcome language barriers in diagnosing mental health conditions 3. Demonstrate cultural competence when interacting with Hispanic and Latinx patients Speakers: Marshall Bruner, PsyD Assistant Professor, Director of the Center for Counseling & Psychological Services, and Assessment Coordinator at Brenau University School of Psychology and Adolescent Counseling Betsy Escamilla, MS Lead School Counselor at Gainesville City School System Vanesa Sarazúa Founder & Executive Director of Hispanic Alliance Georgia No disclosures Objectives Accreditation and Designation: The Northeast Georgia Medical Center & Health System, Inc. is accredited by the Medical Association of Georgia to provide continuing medical education for physicians. The Northeast Georgia Medical Center & Health System, Inc. designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s) TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Enduring CME will expire on 6/8/2025 Speakers: Supriya Mannepalli, MD, CIC, MBA Sandy Bozarth, RN No disclosures Objectives Review Candida auris epidemiology Review infection prevention and control measures to prevent the spread of candida auris Review treatment for Candida auris infections Accreditation and Designation: The Northeast Georgia Medical Center & Health System, Inc. is accredited by the Medical Association of Georgia to provide continuing medical education for physicians. The Northeast Georgia Medical Center & Health System, Inc. designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s) TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Enduring CME will expire on 6/2/2025 Speaker: Mariam Anwar, MD No disclosures Objectives: •Understand early palliative care. •Recognize and identify patients that benefit from early palliative care. •Discuss hospice and non-hospice survival. •Review evidence demonstrating that hospice is associated with longer survival times for certain terminally ill patients Accreditation and Designation: The Northeast Georgia Medical Center & Health System, Inc. is accredited by the Medical Association of Georgia to provide continuing medical education for physicians. The Northeast Georgia Medical Center & Health System, Inc. designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s) TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Enduring CME will expire on 6/1/2025 Speakers: Jaime Morel Ruiz, MD Pathology Addison Parris, MD NGPG Infectious Disease Supriya Mannepalli, MD, MBA, CIC NGHS Medical Director, Infection Prevention No disclosures Objectives: •Discuss clinical presentation of clostridium difficile infection. •Discuss diagnosis and testing of clostridium difficile infection. •Review infection prevention and control best practices for patients with clostridium difficile infection. •Review current guidelines and best practices in management of clostridium difficile infection. Accreditation and Designation: The Northeast Georgia Medical Center & Health System, Inc. is accredited by the Medical Association of Georgia to provide continuing medical education for physicians. The Northeast Georgia Medical Center & Health System, Inc. designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s) TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Enduring CME will expire on 6/26/2025 Speaker: Jeffrey Popma, MD Vice President and Chief Medical Officer, Structural Heart, Coronary and Renal Denervation, Medtronic Professor of Medicine, Emeritus, Harvard Medical School, Boston No disclosures Objectives: • Review the critical value of clinician investigation in the discovery of medical devices to serve unmet patient needs. • Discuss the risks and benefits of transcatheter aortic valve replacement in patients with severe aortic stenosis. • Outline the clinical outcomes associated with transcatheter treatment of patients with symptomatic, severe mitral regurgitation with edge-edge repair and other advanced therapies. Accreditation and Designation: The Northeast Georgia Medical Center & Health System, Inc. is accredited by the Medical Association of Georgia to provide continuing medical education for physicians. The Northeast Georgia Medical Center & Health System, Inc. designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s) TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Enduring CME will expire on 5/11/2024 Speakers: Nathaniel J Kim, MD IM Resident PGY-3 Ahreum Lim, PhD University of Georgia Postdoc Researcher No disclosures Objectives: •Analyze ChatGPT and explain the concept of Large Language Models. •Assess the applications of broad and narrow Artificial Intelligence in clinical medicine and medical education. •Generate discussion concerning the role and necessity of learning in the context of Artificial Intelligence and automation. Accreditation and Designation: The Northeast Georgia Medical Center & Health System, Inc. is accredited by the Medical Association of Georgia to provide continuing medical education for physicians. The Northeast Georgia Medical Center & Health System, Inc. designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s) TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Enduring CME will expire on 5/11/2024 Speaker: Paul Takla, MD No disclosures Objectives: • Decrease stigma surrounding opioid use disorder • Improve ability to identify patients at risk for opioid withdrawal • Understand the pharmacology of Buprenorphine and methadone • Be able to better manage hospitalized patients on Buprenorphine and methadone • Increase use of our hospital's opioid withdrawal protocol • Learn who can initiate patients on opioid substitution therapy • Connect patients with available resources for opioid use disorder Accreditation and Designation: The Northeast Georgia Medical Center & Health System, Inc. is accredited by the Medical Association of Georgia to provide continuing medical education for physicians. The Northeast Georgia Medical Center & Health System, Inc. designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s) TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Enduring CME will expire on 5/11/2024 Learning Objectives: • Improve their knowledge base in substance use disorder in adult patients • Recognize appropriateness of in office treatment versus referral to specialized treatment programs • Improve their knowledge base about medication for opioid use disorder (MOUD) and alcohol use disorder (AUD) Accreditation and Designation: The Northeast Georgia Medical Center & Health System, Inc. is accredited by the Medical Association of Georgia to provide continuing medical education for physicians. The Northeast Georgia Medical Center & Health System, Inc. designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s) TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Enduring CME will expire on 5/10/2024 Objectives: Familiarize the audience with the latest robotic mitral valve technology Detail methods of repair including a live case Education audience on the overlap between transcatheter structural heart technology and robotic cardiac surgery. Disclosures: - There is no commercial support for this activity - The speaker has disclosed the following financial relationships: - Advisory Board – Regeneron - Speaker Bureau – Boehringer Ingelheim, Amgen, and Esperion Accreditation and Designation: The Northeast Georgia Medical Center & Health System, Inc. is accredited by the Medical Association of Georgia to provide continuing medical education for physicians. The Northeast Georgia Medical Center & Health System, Inc. designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s) TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Objectives: Recognize the association between post-COVID syndrome (or long COVID syndrome) and post-COVID tachycardia. Identify the difference between post-COVID tachycardia and inappropriate sinus tachycardia and postural orthostatic tachycardia syndrome. Discuss the demographics, comorbidities and severity of COVID-19 infection associated with post-COVID tachycardia.
Objectives: Understand the pathophysiology of chronic subdural hematomas Know the techniques for neurointervention in subdural hematoma Review the recent research outcomes on endovascular techniques in chronic subdural hematomas
Objectives: •Understand Heart Failure with Preserved Ejection Fraction (HFpEF), including definitions, signs, symptoms, and risk factors. •Discuss the proposed pathophysiology of heart failure with both preserved and reduced ejection fractions. •Review the new trial called “MyPACE” to discuss effects of personalized accelerated pacing in patients with HFpEF.
Objectives: • Examine what is POLST and its use in Northeast Georgia Health System. • Review patient criteria for POLST qualification. • Understand POLST's role in assisting patients with expressing their medical wishes. • Recognize when POLST is appropriate for patient completion.
Today's Speaker: ZAHI A. FAYAD, PHD, FAHA, FACC, FISMRM Director, BioMedical Engineering and Imaging Institute Professor of Medicine, Division of Cardiology Icahn School of Medicine, Mount Sinai School, NY Disclosures: Grant/research support from NIH. Consultant for Trained Therapeutix Discovery and Co-founder/Board of directors for Trained Therapeutix Discover. Objectives: •Understand personalized patient care. How to implement personalized care. Understand the expected outcomes from personalized care.
Today's Speaker: Rosemary Chofor, MD IM Resident, PGY-3 Objectives: • Define polypharmacy and deprescribing. • Recognize patients at risk for deleterious effects of polypharmacy. • Integrate screening tools when completing medication reconciliation. • List the strategies that can help minimize polypharmacy.
Today's Speaker: Speaker: Oluseyi Abidoye, MD Objectives: - Review and understand the pathophysiology of VTEs in patients with traumatic fractures - Understand role of Antithrombotic agents in preventing VTEs in post-surgical patients - Review current guidelines of VTE prevention in patients with fractures - Understand the Role of Aspirin as a single agent for venous thrombophylaxis in patients after extremity fracture
Today's Speaker: Sahil Parag, DO IM Resident, PGY-3 Objectives: 1. Understand the mechanism of action of Finerenone, and how it differs from currently used mineralocorticoid receptor antagonists 2. Identify patients that may benefit from addition of this medication 3. Understand adverse effects and monitoring for these patients 4. Identify the recommendations for specific population that may benefit from use of this medication along with current guidelines 5. Understand patients who this medication would be contraindicated despite have ckd and diabetes
Speakers: Jaime Morel Ruiz, MD Pathology William O'Sick, MLS (ASCP)CM Microbiology Supervisor, Laboratory Objectives: • Detail the most common samples received from microbiology testing. • Explain proper sample collection and its intended uses. • Detail adequacy requirements for microbiology samples. • Clarify expectations from microbiology reports.
Speaker: Hadia Ahmad, MD IM Resident PGY-3 No Disclosures Objectives: •Define treatment resistant hypertension. •Understand the role of endothelin and aldosterone in the pathophysiology of hypertension. •Recognize the endothelin pathway as a target for treatment of resistant hypertension. •Review current research investigating endothelin-receptor antagonists and aldosterone synthase in the treatment of hypertension.
No Disclosures Learning Objectives: 1. Identify what delirium is 2. Identify the current practices of delirium 3. Be able to explain why the current practices for delirium management are limited 4. Predict the direction of the future of delirium management
© 2020-2025 Ivy Podcast Discovery LLC
